Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
5.31
-0.03 (-0.56%)
At close: May 8, 2026, 4:00 PM EDT
5.32
+0.01 (0.19%)
After-hours: May 8, 2026, 7:49 PM EDT
Cybin Employees
Cybin had 50 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,464,346
Market Cap
265.69M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | 37 | 3,700.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Coherus Oncology | 147 |
| Codexis | 146 |
| Arcturus Therapeutics Holdings | 111 |
| Foghorn Therapeutics | 106 |
| Artiva Biotherapeutics | 104 |
| Compugen | 75 |
| Cartesian Therapeutics | 75 |
HELP News
- 10 days ago - CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - GlobeNewsWire
- 10 days ago - Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference - GlobeNewsWire
- 12 days ago - Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - GlobeNewsWire
- 17 days ago - Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan - GlobeNewsWire
- 20 days ago - How Trump's psychedelics executive order could unlock stalled cannabis reform - CNBC
- 20 days ago - Helus ‘welcomes’ Executive Order for accelerating psychedelic research - TheFly
- 20 days ago - Helus Pharma announces Cola is stepping down as CEO, appoints So as Interim CEO - TheFly
- 20 days ago - Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions - GlobeNewsWire